Acob, Abdilla C.
HRN: 27-08-67 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/25/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/25/2025
05/31/2025
IV
525
Q12
Cap-HR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes